Adept2 rFVIIa analogue

recombinant activated factor VII analogue · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adept2 rFVIIa analogue, covering 2019-01-04 to 2019-01-04. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial [Phase 2]

See pricing